News

Advancing medicine, step by step

Learn of and follow our journey to bring about Therapeutic Mitochondria Transfer as a new treatment modality

News News

News & Publications

News

10.03.2021

CELLVIE CEO Dr. Alexander Schueller placed amongst the Top-17 contenders for the De Vigier Awards 2021

cellvie AG is proud to announce that CEO Dr. Alexander Schueller placed amongst the Top-17 contenders for the prestigious De Vigier Entrepreneurship Award.

Read more

News

28.01.2021

CELLVIE closes $5M Seed Round led by Kizoo Technology

Harvard spin-off CELLVIE closes $5M seed round in pursuit of a new treatment modality: therapeutic mitochondria transfer

Read more

News

18.11.2020

CELLVIE wins the prestigious MedTech Innovator Value Award

CELLVIE palces among the final 5 contenders for the grant prize of the MedTech Innovator Award and takes home the prestigious MedTech Innovator Value Award

Read more

News

10.07.2020

CELLVIE’s mitochondria treatment has been granted orphan-drug designation from the FDA

cellvie has been granted orphan-drug designation for the use of mitochondria in the prevention of ischemia-reperfusion injury during solid organ transplantation.

Read more
Cellvi Logo Cellvi Logo 2

Get in touch!

Contact